First Wave BioPharma
Why Robinhood?
You can watch FWBI and buy or sell other stocks, ETFs, and their options commission-free!About FWBI
Entero Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide.
FWBI Key Statistics
Stock Snapshot
As of today, First Wave BioPharma(FWBI) shares are valued at $2.16. The company's market cap stands at 3.43M, with a P/E ratio of -0.44.
First Wave BioPharma(FWBI) stock opened on 2026-07-26 at —. The price climbed to — and dipped to —.
The First Wave BioPharma(FWBI)'s current trading volume is 0, compared to an average daily volume of 204.95K.
In the last year, First Wave BioPharma(FWBI) shares hit a 52-week high of $5.84 and a 52-week low of $0.97.
In the last year, First Wave BioPharma(FWBI) shares hit a 52-week high of $5.84 and a 52-week low of $0.97.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.